Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. logo
MDGL

Madrigal Pharmaceuticals, Inc. (MDGL)

$66.912.56%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$64.225
Day's Range
$67.81
$52.33
52-Week Range
$105.93
1 month return3.48%
3 month return6.06%
1 year return7.51%
5 year return18.42%

Company Information

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Madrigal recognizes that compounds with greater selectivity for thyroid hormone receptor (THR)-ß and liver uptake has the greatest potential to overcome challenges faced by prior, less selective compounds and deliver the full therapeutic potential of THR-ß agonism. The Company believes that resmetirom, its lead product candidate, is the first orally administered, small-molecule, liver-directed, truly ß-selective THR agonist.
OrganizationMadrigal Pharmaceuticals, Inc.
Employees71
CEODr. Paul A. Friedman M.D.
IndustryHealth Technology

Analyst Recommendation

based on 14 analysts ratings

Buy
85%
Buy
7%
Hold
7%
Sell

Based on 14 Wall street analysts offering stock ratings for Madrigal Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 128.04%

Current

$66.91

Target

$152.58

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
12
16
16
Hold
1
2
2
Sell
1
1
1
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
1.1B
Book Value
$0.62
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-14.65
PEG Ratio
0.0
Wall Street Target Price
152.58

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
104.58
Enterprise Value
1.0B
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-3.72

Technicals

Beta
0.89
50 Day MA
69.16
200 Day MA
74.09

Institutional Holdings

venBio Select Advisor LLC

8.97%

Baker Bros Advisors LP

8.77%

Vanguard Group Inc

7.33%

Armistice Capital, LLC

7.23%

BlackRock Inc

5.84%

State Street Corporation

5.65%

Discover more

Frequently Asked Questions

What is Madrigal Pharmaceuticals, Inc. share price today?

Can Indians buy Madrigal Pharmaceuticals, Inc. shares?

How can I buy Madrigal Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Madrigal Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Madrigal Pharmaceuticals, Inc. stocks?

What are today’s High and Low prices of Madrigal Pharmaceuticals, Inc.?

What are today’s traded volumes of Madrigal Pharmaceuticals, Inc.?

What is today’s market capitalisation of Madrigal Pharmaceuticals, Inc.?

What is the 52 Week High and Low Range of Madrigal Pharmaceuticals, Inc.?

How much percentage Madrigal Pharmaceuticals, Inc. is down from its 52 Week High?

How much percentage Madrigal Pharmaceuticals, Inc. is up from its 52 Week low?

What are the historical returns of Madrigal Pharmaceuticals, Inc.?

Who is the Chief Executive Officer (CEO) of Madrigal Pharmaceuticals, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*